Literature DB >> 16443907

Diabetes and coronary risk equivalency: what does it mean?

Scott M Grundy.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16443907     DOI： 10.2337/diacare.29.02.06.dc05-1904

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  19 in total

Review 1.  Prognostic utility of coronary computed tomographic angiography.

Authors:  Yuka Otaki; Daniel S Berman; James K Min
Journal:  Indian Heart J       Date:  2013-04-12

2.  Should Statins Be Started In All Type 2 Diabetics Irrespective of LDL-Cholesterol Level?

Authors:  Ss Vasanthakumar; Cl Teng
Journal:  Malays Fam Physician       Date:  2007-08-31

3.  Long-term risk of coronary events after AKI.

Authors:  Vin-Cent Wu; Che-Hsiung Wu; Tao-Min Huang; Cheng-Yi Wang; Chun-Fu Lai; Chih-Chung Shiao; Chia-Hsui Chang; Shuei-Liong Lin; Yen-Yuan Chen; Yung-Ming Chen; Tzong-Shinn Chu; Wen-Chih Chiang; Kwan-Dun Wu; Pi-Ru Tsai; Likwang Chen; Wen-Je Ko
Journal:  J Am Soc Nephrol       Date:  2014-02-06       Impact factor: 10.121

4.  Diabetes, diabetes severity, and coronary heart disease risk equivalence: REasons for Geographic and Racial Differences in Stroke (REGARDS).

Authors:  Favel L Mondesir; Todd M Brown; Paul Muntner; Raegan W Durant; April P Carson; Monika M Safford; Emily B Levitan
Journal:  Am Heart J       Date:  2016-08-12       Impact factor: 4.749

5.  Vitamin D₃ prevents the increase in ectonucleotidase activities and ameliorates lipid profile in type 1 diabetic rats.

Authors:  Nicéia Spanholi Calgaroto; Pauline da Costa; Andréia Machado Cardoso; Luciane Belmonte Pereira; Juliano Marchi Vieira; Diéssica Dalenogare; Luana Paula Pelinson; Jucimara Baldissarelli; Vera Maria Morsch; Maria Rosa Chitolina Schetinger
Journal:  Mol Cell Biochem       Date:  2015-04-17       Impact factor: 3.396

6.  Is diabetes mellitus equivalent to atherosclerotic cardiovascular disease from a healthcare cost perspective? Insights from the Medical Expenditure Panel Survey: 2010-2013.

Authors:  David I Feldman; Javier Valero-Elizondo; Joseph A Salami; Jamal S Rana; Oluseye Ogunmoroti; Victor Okunrintemi; Chukwuemeka U Osondu; Erica S Spatz; Salim S Virani; Ron Blankstein; Michael J Blaha; Emir Veledar; Khurram Nasir
Journal:  Cardiovasc Endocrinol Metab       Date:  2018-08-15

7.  What have we learned from CONFIRM? Prognostic implications from a prospective multicenter international observational cohort study of consecutive patients undergoing coronary computed tomographic angiography.

Authors:  Yuka Otaki; Reza Arsanjani; Heidi Gransar; Victor Y Cheng; Damini Dey; Troy Labounty; Fay Y Lin; Stephan Achenbach; Mouaz Al-Mallah; Matthew J Budoff; Filippo Cademartiri; Tracy Q Callister; Hyuk-Jae Chang; Kavitha Chinnaiyan; Benjamin J W Chow; Augustin Delago; Martin Hadamitzky; Joerg Hausleiter; Philipp Kaufmann; Erica Maffei; Gilbert Raff; Leslee J Shaw; Todd C Villines; Allison Dunning; Ricardo C Cury; Gudrun Feuchtner; Yong-Jin Kim; Jonathon Leipsic; Daniel S Berman; James K Min
Journal:  J Nucl Cardiol       Date:  2012-08       Impact factor: 5.952

Review 8.  Lipid control in patients with diabetes mellitus.

Authors:  D John Betteridge
Journal:  Nat Rev Cardiol       Date:  2011-03-15       Impact factor: 32.419

9.  Association between LDL-C and risk of myocardial infarction in CKD.

Authors:  Marcello Tonelli; Paul Muntner; Anita Lloyd; Braden Manns; Scott Klarenbach; Neesh Pannu; Matthew James; Brenda Hemmelgarn
Journal:  J Am Soc Nephrol       Date:  2013-05-16       Impact factor: 10.121

10.  Association of impaired fasting glucose and coronary artery calcification as a marker of subclinical atherosclerosis in a population-based cohort--results of the Heinz Nixdorf Recall Study.

Authors:  S Moebus; A Stang; S Möhlenkamp; N Dragano; A Schmermund; U Slomiany; B Hoffmann; M Bauer; M Broecker-Preuss; K Mann; J Siegrist; R Erbel; K-H Jöckel
Journal:  Diabetologia       Date:  2008-11-01       Impact factor: 10.122
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.